News

PEPperPRINT's unique peptide microarray platform is based on a completely new approach of combinatorial synthesis: Instead of using e.g. standard spotters or lithographic synthesis, amino acid micro particles are printed...

[more]

According to WHO, 49 laboratory-confirmed cases of human infection with novel Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported so far. Due to the severe acute respiratory disease of most...

[more]

PEPperPRINT is sponsoring the Deutsche Biotechnologietage 2013 taking place from May 14-15 in Stuttgart, Germany. We cordially invited to meet us at Booth 11 in the Exhibition Area to learn more on our new PEPperCHIP®...

[more]

We are pleased to announce that PEPperPRINT has signed a distribution agreement with Seoul-based AbClon Inc. Under the terms of the agreement AbClon has the exclusive marketing and sales rights for PEPperPRINT products...

[more]

PEPperPRINT released two new application notes on the use of the PEPperCHIP® Peptide Microarrays. The first application note describes the permutation scan of two known epitopes, HA and M13, for the in-depth analysis of...

[more]

The new PEPperCHIP® Autoimmunity Microarray covers 2,733 linear B-cell epitopes associated with autoimmune diseases from the Immune Epitope Database including 187 citrullinated peptides as well as the corresponding...

[more]

PEPperPRINT's high content peptide microarray platform PEPperCHIP® is introduced in present Science Magazine issue (Vol. 339, issue 6121, 2013) along with other new life science products from Roche and Qiagen. Science's...

[more]